Post hoc analysis of PROTECTED TAVR finds reduced stroke risk in the U.S. but not beyond
Analysis of STS/ACC TVT Registry finds greatest benefit in patients with prior stroke
Results from largest randomized trial of the technology to date
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Advertisement